RNHD | Shalek: Identifying & Counteracting the Impact of Environment Stress on Tissue Function
Alex K. Shalek, PhD, Director, Institute for Medical Engineering & Science and Health Innovation Hub, MIT; J. W. Kieckhefer Professor, Institute for Medical Engineering & Science, Department of Chemistry, and Koch Institute, MIT; Ragon Institute | Broad Institute | HMS | MGB
to
RNHD | Houlahan: Germline-mediated immunoediting in cancer
Kathleen Houlahan, PhD, Assistant Professor, Department of Biochemistry & Biomedical Sciences, Principal Investigator, Centre for Discovery in Cancer Research, McMaster University
to
RNHD | Stockwell: Ferroptosis and metabolism—mechanisms and therapeutic implications
Brent R. Stockwell, PhD, William R. Kenan, Jr. Professor of Biological Sciences; Chair, Department of Biological Sciences, and Professor of Chemistry, Columbia University; and Professor of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
to
RNHD | Dessauer: Spatial Landscape of Adenylyl Cyclase Signaling
Carmen W. Dessauer, PhD, Professor and Chair, Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, TX
to
RNHD | Rajagopal: Spatiotemporal Organization of G protein-coupled receptor signaling
Sudarshan Rajagopal, MD, PhD, Associate Professor, Department of Medicine, Duke University School of Medicine
to
RNHD | Tuveson: Pancreatic Cancer Biology and Medicine
David Tuveson, MD, PhD, Roy J. Zuckerberg Professor of Cancer Research, Cancer Center Director, Cold Spring Harbor Laboratory
to
RNHD | Pecot: New Frontiers in RNA Structure and Therapeutics to Combat Cancer
Chad Pecot, PhD, Professor, Department of Medicine, Director, UNC RNA Discovery Center, Co-Leader, UNC Lineberger Cancer Therapeutics Program
to
RNHD | Palmer: The impact of patient heterogeneity and treatment sequence in combination cancer therapy
Adam Palmer, PhD, Assistant Professor, Department of Pharmacology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
to
RNHD | Feng: Deciphering the anti-oncogenic effect of oncoproteins
Gen-Sheng Feng, PhD, Senior Investigator and Director, Institute of Cancer Research, Shenzhen Bay Laboratory
to